Infectious agents and inflammatory processes contribute to a range of heart diseases, some of which can lead to long-term cardiac complications if not treated adequately. Myocarditis, an inflammation of the heart muscle, and infective endocarditis, an infection of the heart valves, are among the most concerning infectious causes of heart disease. These conditions often present with nonspecific symptoms, making early diagnosis a challenge. Inflammatory responses, whether triggered by infections or autoimmune diseases, can disrupt the normal function of the heart, causing arrhythmias, heart failure, or even sudden cardiac death. Managing infections and inflammatory heart diseases typically requires a combination of antimicrobial treatments and anti-inflammatory medications, along with close monitoring to prevent further heart damage. Timely intervention can significantly improve prognosis and prevent the development of chronic heart conditions.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Therapeutic pneumoperitoneum mimicking inferior myocardial infarction and right ventricular aneurysm: A case report
Abhinav Prithvi Venkata Sesha Kanigicherla, University Hospital Coventry and Warwickshire NHS Trust, United Kingdom
Title : Multisystem IgG4-related disease with cardiac involvement mimicking cardiac sarcoidosis: a diagnostic challenge background
Natasha Manuelpillai, Salisbury District Hospital- NHS, United Kingdom
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation